Protection assessments indicated that gastrointestinal adverse situations, mainly nausea and diarrhea, ended up dose-dependent but generally gentle and transient. These conclusions set up the therapeutic window and educated dose selection for subsequent Stage three trials.In the event you’re thinking about exploring weight loss medication, see fo